UNSPSC 51285607: Lasalocid sodium

This classification denotes an antibiotic with the molecular formula C34H53O8.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W2S5C71Y3G, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-, monosodium salt. (-)- but more generally known as lasalocid sodium, which bears US NIH Compound Identifier 33265. Most nations schedule lasalocid sodium under HS 29419000.

As of Q4 2014, LASALOCID SODIUM remains the US FDA Preferred Term for this commodity. Lasalocid sodium bears US NLM identifiers UMLS ID C0878439 and NCI Concept Code C79535. SMILES: CC[C@H]([C@@H]1[C@H](C[C@@](O1)(CC)[C@H]2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCC3CCC(C(C3C(=O)[O-])O)C)O.[NA+].

UNSPSC 51285607 Lasalocid sodium is a Commodity code that does not align with actual state and local purchasing activity in the recent opportunities record. The code nominally describes an animal-feed additive, yet the recent solicitations posted under this code address naloxone procurement, pharmaceutical supply programs, and medical first-aid supplies—none of which involve lasalocid sodium or animal health products. The mismatch suggests a data-classification issue rather than active demand for the commodity itself. State and local procurement systems occasionally tag opportunities with codes that do not match the work being bought, and this code shows no relevant recent activity.

The four opportunities in the record span health departments, cooperative purchasing alliances, and fire rescue divisions across Florida, Texas, and Minnesota, but none involve lasalocid sodium or animal-feed supply. Seminole County, Florida posted an IFB (due July 26, 2023, with a posting date of June 30, 2026—internally inconsistent dates that suggest data quality issues) for naloxone and drug deactivation systems; the City of Tampa posted an IFB (due March 13, 2026) for medical and first-aid supplies to the fire department; the Texas Health and Human Services Commission issued an RFI (April 3, 2026) on direct-to-manufacturer pharmacy programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (due March 26, 2026) for generic pharmaceuticals and OTC products distributed through authorized wholesalers. None of these solicitations involve the commodity described by the code. If your firm supplies animal-feed additives, this code does not currently reflect actionable state and local demand.